Clin Lung Cancer
Antibodies, MonoclonalCarcinoma, Non-Small-Cell LungLung Neoplasms
Dr. Michael K. Cohenuram, MD
NPI1043409691PAC ID5193709525
- Medicare services, 2024
- 687
- Medicare patients, 2024
- 260
- Part D claims, 2024
- 1,997
- Publications
- 1
- Clinical trials
- 5
- Practice address
- 50 Division St, New Haven, CT 06511
- Practice phone
- Call (203) 785-2140
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Yale Medicine
New Haven, Connecticut
Find Dr. Cohenuram's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael K. Cohenuram is a hematologist and oncologist in New Haven, Connecticut
Dr. Cohenuram practices at Yale Medicine in New Haven, Connecticut.
Dr. Cohenuram's NPI, 1043409691, was assigned on October 19, 2007. Dr. Cohenuram graduated from Icahn School of Medicine at Mount Sinai in 2000. Dr. Cohenuram holds Connecticut license 045754.
NPI and contact details
- NPI
- 1043409691NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5193709525
- NPI enumeration date
- October 19, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (203) 785-2140
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael K. Cohenuram practices at Yale Medicine in New Haven, Connecticut
Dr. Cohenuram's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.
- Yale Medicine50 Division St, New Haven, CT 06511 · South Central Ct CountyPhone(203) 785-2140
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Michael K. Cohenuram is affiliated with 7 sites of care and 1 medical group
Dr. Cohenuram's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Cohenuram is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Cohenuram to 4 more hospitals and 1 hospice, each named with a free account.
Yale MedicinePrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael K. Cohenuram's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cohenuram practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Yale Medicine | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Cohenuram practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael K. Cohenuram is one of 175 hematologists and oncologists in Connecticut
Hematology and oncology is Dr. Cohenuram's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cohenuram is licensed in Connecticut.
Specialties and state licenses
- Hematology and oncology, ConnecticutPrimary
Hematologists and oncologists near Dr. Cohenuram
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael K. Cohenuram billed Medicare for 687 services in 2024
CMS data shows 687 Medicare services from Dr. Cohenuram across 5 procedure codes in 2024, for 260 Medicare patients. Medicare paid $58,337 for them.
Medicare services, 2024687
Medicare patients260
Paid by Medicare$58,337
Procedure codes5
Dr. Cohenuram's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8242024: 68717%
Where Dr. Cohenuram's Medicare services took place, 2024
- In an office64694%
- In a facility416%
Dr. Cohenuram compared with the Connecticut median for hematologists and oncologists, 2024
- Dr. Cohenuram
- Connecticut median
- Medicare services
- 687vs 54127% above
- Medicare patients
- 260vs 20825% above
- Part D claims
- 1,574vs 4513.5 times
Medians across 168 hematologists and oncologists in Connecticut with Dmand AI profiles that report each measure.
Dr. Cohenuram's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Cohenuram?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Cohenuram and other hematologists and oncologists in Connecticut.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael K. Cohenuram treated 260 Medicare patients in 2024, average age 75
CMS counts 260 Medicare patients who saw Dr. Cohenuram in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have cancer, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Cohenuram's median patient age at 73, with 64% women.
Medicare patients, 2024260
Average age75
Average risk score2.09
Also on Medicaid22%
Dr. Cohenuram's Medicare patients by age, 2024
Dr. Cohenuram's Medicare patients by sex, 2024
- Women17668%
- Men8432%
Chronic conditions among Dr. Cohenuram's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure71%
- Arthritis54%
- Anxiety35%
- COPD33%
- Mood disorders31%
- Depression28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Cohenuram's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women64%
- Men34%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Michael K. Cohenuram wrote 1,997 Medicare Part D claims in 2024
In 2024, Dr. Cohenuram wrote 1,997 Medicare Part D claims for 305 patients. 81% of them were for generic drugs. CMS names the drug for 1,574 of them, across 48 drugs with 11 or more claims each, at $3,018,856 in total drug cost. In 2023, CMS named 1,656 claims across 49 drugs.
Part D claims, 20241,997
Drugs named by CMS48
Total drug cost$3M
Part D patients305
Dr. Cohenuram's Part D claims by kind of drug, 2024
- Generic1,617 claims81%
- Brand-name380 claims19%
Dr. Cohenuram's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Cohenuram's Part D claims, 2024
- Opioids8%160 of 1,997 claims
- Antibiotics2%48 of 1,997 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,6562024: 1,5745%
Drugs named by CMS: 48 in 2024, 49 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Michael K. Cohenuram scored 87 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cohenuram for performance year 2024, reported as part of a group. Dr. Cohenuram accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cohenuram as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Cohenuram's MIPS scores, performance year 2024
- 87of 100Final score
- 77.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Cohenuram by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael K. Cohenuram has 1 publication on record
Dmand AI links 1 paper to Dr. Cohenuram in 2021.
Papers1
Recent publications by Dr. Cohenuram
See who Dr. Cohenuram researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cohenuram works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael K. Cohenuram has worked on 5 clinical trials
Dmand AI links Dr. Cohenuram to 5 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Rectal Diseases. National Cancer Institute (NCI) sponsors the most, 3.
Clinical trials with Dr. Cohenuram by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Cohenuram's trials
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Rectal Diseases
- Ureteral Neoplasms
- Brain Neoplasms
Investigators on the most trials with Dr. Cohenuram
Recent clinical trials with Dr. Cohenuram
Rectal DiseasesColorectal NeoplasmsAtezolizumabBevacizumabFluorouracil
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (opens in a new tab)
Active, not recruitingPhase 3
Ureteral NeoplasmsUreteral DiseasesPembrolizumab
Breast Cancer WEight Loss Study (BWEL Study) (opens in a new tab)
Active, not recruitingPhase 3
Breast NeoplasmsBreast Diseases
Triple Negative Breast NeoplasmsBrain NeoplasmsCisplatinVeliparib
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (opens in a new tab)
Active, not recruitingPhase 3
Triple Negative Breast NeoplasmsBreast NeoplasmsCapecitabineCarboplatinCisplatin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael K. Cohenuram received $5,023 in industry payments from 2016 to 2025
CMS Open Payments shows 248 general payments to Dr. Cohenuram from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Bristol-Myers Squibb Company paid the most, $572. It also lists 1 research payment totaling $63 in 2016.
General payments to Dr. Cohenuram by program year, 2016 to 2025
General payments to Dr. Cohenuram by kind, 2016 to 2025
$5Kin total
- Food and beverage$4,54290%
- Education$3096%
- Travel and lodging$1733%
Companies that paid Dr. Cohenuram the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael K. Cohenuram graduated from Icahn School of Medicine at Mount Sinai
Dr. Cohenuram graduated from Icahn School of Medicine at Mount Sinai in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael K. Cohenuram's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael K. Cohenuram
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael K. Cohenuram's NPI number?
Dr. Michael K. Cohenuram's NPI number is 1043409691. It was assigned on October 19, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael K. Cohenuram?
Dr. Michael K. Cohenuram is a hematologist and oncologist in New Haven, Connecticut. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Michael K. Cohenuram practice?
Dr. Cohenuram practices at 50 Division St, New Haven, CT 06511. Dr. Cohenuram's primary practice is Yale Medicine in New Haven, Connecticut. Dmand AI also links Dr. Cohenuram to 4 hospitals and 1 hospice.
What is Dr. Michael K. Cohenuram's office phone number?
The practice phone on file for Dr. Cohenuram is (203) 785-2140.
What is Dr. Michael K. Cohenuram's medical license number?
Dr. Cohenuram holds Connecticut license 045754.
Which hospitals is Dr. Michael K. Cohenuram affiliated with?
Dr. Cohenuram is affiliated with Yale New Haven Hospital. Dmand AI links Dr. Cohenuram to 4 more hospitals.
What medical group is Dr. Michael K. Cohenuram part of?
Dr. Cohenuram is linked to Yale Health.
Does Dr. Michael K. Cohenuram accept Medicare?
Yes. CMS data shows Dr. Cohenuram billed Medicare for 687 services in 2024, and Dr. Cohenuram accepts Medicare assignment.
Does Dr. Michael K. Cohenuram offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Cohenuram as offering telehealth services.
What is Dr. Michael K. Cohenuram's MIPS score?
Dr. Cohenuram's MIPS final score for performance year 2024 is 87 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Michael K. Cohenuram see?
CMS counts 260 Medicare patients who saw Dr. Cohenuram in 2024, with an average age of 75.
What services does Dr. Michael K. Cohenuram bill to Medicare?
In 2024, Dr. Cohenuram's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99232).
Where did Dr. Michael K. Cohenuram go to medical school?
Dr. Cohenuram graduated from Icahn School of Medicine at Mount Sinai in 2000.
What drugs does Dr. Michael K. Cohenuram prescribe most?
In 2024 Medicare Part D data, Dr. Cohenuram's most prescribed drugs by claims were Tamoxifen Citrate, Anastrozole and Letrozole.
Has Dr. Michael K. Cohenuram received payments from drug or device companies?
CMS Open Payments shows $5,023 in general payments to Dr. Cohenuram from 41 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Michael K. Cohenuram been practicing?
Dr. Cohenuram graduated from medical school in 2000, 26 years ago.
Does Dr. Michael K. Cohenuram do research?
Dmand AI links 1 publication to Dr. Cohenuram. Dr. Cohenuram has worked on 5 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card